Presentation and clinical features of severe sepsis

Journal of the Royal College of Physicians of London

Volumn 34, Issue 5, 2000, Pages 418-423

  Green, Justin ^a   Lynn, William A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

FEMALE; HUMAN; INCIDENCE; ISOLATION AND PURIFICATION; MICROBIOLOGY; MORTALITY; NEISSERIA MENINGITIDIS; PATHOPHYSIOLOGY; REVIEW; RISK FACTOR; SEPSIS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PYOGENES;

FEMALE; HUMANS; INCIDENCE; NEISSERIA MENINGITIDIS; RISK FACTORS; SEPSIS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PYOGENES;

EID: 0034280655     PISSN: 00358819     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Bone RC. Sepsis, the sepsis syndrome, multi-organ failure: a plea for comparable definitions. Ann Intern Med 1991;114:332-3.
2. McCabe WR, Jackson GG. Gram-negative bacteremia II. Clinical, laboratory, and therapeutic observations. Arch Intern Med 1962;110:856-64.
3. Bone RC, Balk RA, Cerra FB, Dellinger RP, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992;101:1644-55.
4. Vincent JL. Dear SIRS, I'm sorry to say that I don't like you. Crit Care Med 1997;25:372-4.
5. Kieft H, Hoepelman Al, Zhou W, Rozenberg-Arska M, et al. The sepsis syndrome in a Dutch university hospital. Clinical observations. Arch Intern Med 1993;153:2241-7.
6. Wenzel RP. The mortality of hospital-acquired blood stream infections: need for a new vital statistic. Int J Epidemiol 1988;17:225-7.
7. Quartin AA, Schein RM, Kett DH, Peduzzi PN. Magnitude and duration of the effect of sepsis on survival. Department of Veterans Affairs Systemic Sepsis Cooperative Studies Group. JAMA 1997;277:1058-63.
8. Wenzel RP, Pinsky MR, Ulevitch RJ, Young L. Current understanding of sepsis. Clin Infect Dis 1996;22:407-12.
9. Vincent JL, Bihari DJ, Suter PM, Bruining HA, et al. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. JAMA 1995;274:639-44.
10. Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, et al. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 1995;273:117-23.
11. Bone RC. Towards an epidemiology and natural history of SIRS (systemic inflammatory response syndrome). JAMA 1992;268:3452-5.
12. Rayner BL, Willcox PA. Community-acquired bacteraemia; a prospective study of 239 cases. Q J Med 1988;69:907-19.
13. Brun Buisson C, Doyon F, Carlet J. Bacteremia and severe sepsis in adults: a multicenter prospective survey in ICUs and wards of 24 hospitals. French Bacteremia-Sepsis Study Group. Am J Respir Crit Care Med 1996;154:617-24.
14. Cohen J, Carlet J. INTERSEPT: an international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis. Crit Care Med 1996; 24:1431-40.
15. Fisher CJ, Dhainaut J-F, Opal SM, Pribble JP, et al. Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome: results from a randomized, double-blind placebo-controlled trial. JAMA 1994; 271:1836-43.
16. McCabe WR, Jackson GG. Gram-negative bacteremia I. Etiology and ecology. Arch Intern Med 1962;110:847-55.
17. Burhard KW. Fungal sepsis. Infect Dis Clin North Am 1992;6:677-92.
18. Lynn WA. Sepsis. In: Cohen J, Armstrong D (eds). Infectious diseases. London: Mosby, 1999: Section 2, 47.1-47.14.
19. Kaczmarski EB, Ragunathan PL, Marsh J, Gray SJ, et al. Creating a national service for the diagnosis of meningococcal disease by polymerase chain reaction. Commun Dis Pub Health 1998;1:54-6.
20. Casey LC, Balk RA, Bone RC. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 1993; 119:771-8.
21. van Dissel JT, van Langevelde P, Westendorp RGJ, Kwappenberg K, et al. Anti-inflammatory cytokine profile and mortality in febrile patients. Lancet 1998;351:1125-8.